Back to DatabaseNot FDA Approved
GHK-Cu
Also known as: Copper Peptide GHK, Glycyl-L-histidyl-L-lysine:copper(II)
Anti-Aging
Phase II
GHK-Cu is a naturally occurring copper-binding tripeptide with remarkable regenerative properties. It was discovered when researchers found that albumin from young individuals (age 20-25) could stimulate old liver tissue to produce proteins characteristic of youth. GHK-Cu was identified as the active component.
Regulatory & Approval Status
GHK-Cu is not FDA-approved as an injectable drug. It has reached Phase 2 clinical trials for wound healing, and while topical forms are sometimes used, the injectable route is not eligible for 503A compounding.
Information compiled from FDA compounding guidance and public regulatory sources. For research and educational purposes only; not medical advice.